Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 5470241, 8 pages
https://doi.org/10.1155/2017/5470241
Research Article

Mechanism of Reduced Susceptibility to Fosfomycin in Escherichia coli Clinical Isolates

1Department of Microbiology, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo 060-8556, Japan
2Department of Clinical Laboratory, NTT East Sapporo Hospital, Chuo-ku, Sapporo 060-0061, Japan

Correspondence should be addressed to Shin-ichi Yokota; pj.ca.dempas@atokoys

Received 15 July 2016; Revised 22 December 2016; Accepted 27 December 2016; Published 19 January 2017

Academic Editor: Yun-Peng Chao

Copyright © 2017 Yasuo Ohkoshi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, “Antimicrobial resistance: global report on surveillance 2014,” 2014, http://www.who.int/drugresistance/documents/surveillancereport/en/.
  2. M. E. Falagas and D. E. Karageorgopoulos, “Extended-spectrum β-lactamase-producing organisms,” Journal of Hospital Infection, vol. 73, no. 4, pp. 345–354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. D. D. Pitout, “Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment,” Expert Review of Anti-Infective Therapy, vol. 10, no. 10, pp. 1165–1176, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Yokota, T. Sato, T. Okubo et al., “Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M15-nonproducing) strains isolated in Japan,” Chemotherapy, vol. 58, no. 1, pp. 52–59, 2012. View at Google Scholar
  5. N. Tsukamoto, Y. Ohkoshi, T. Okubo et al., “High prevalence of cross-resistance to aminoglycosides in fluoroquinolone-resistant Escherichia coli clinical isolates,” Chemotherapy, vol. 59, no. 5, pp. 379–384, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Giamarellou and G. Poulakou, “Multidrug-resistant gram-negative infections: what are the treatment options?” Drugs, vol. 69, no. 14, pp. 1879–1901, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. E. Falagas, A. C. Kastoris, A. M. Kapaskelis, and D. E. Karageorgopoulos, “Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review,” The Lancet Infectious Diseases, vol. 10, no. 1, pp. 43–50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Schaeffer, “Infections of the urinary tract,” in Campbell-Walsh Urology, A. Wein, L. Kavoussi, A. Novick, A. Partin, and C. Peters, Eds., pp. 223–303, Elsevier, Philadelphia, Pa, USA, 9th edition, 2007. View at Google Scholar
  9. K. Ishikawa, R. Hamasuna, S. Uehara et al., “Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases,” Journal of Infection and Chemotherapy, vol. 21, no. 9, pp. 623–633, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. D. N. Gilbert, H. F. Chambers, G. M. Eliopoulos, and M. S. Saag, The Sanford Guide to Antimicrobial Therapy 2015, Antimicrobial Therapy, Sperryville, Va, USA, 45th edition, 2015.
  11. The Japanese Association for Infectious Diseases and Japan Society of Chemotherapy, The JAID/JSC Guide to Clinical Management of Infectious Diseases 2014, The Japanese Association for Infectious Diseases/Japan Society of Chemotherapy, Tokyo, Japan, 2014 (Japanese).
  12. E. D. Brown, E. I. Vivas, C. T. Walsh, and R. Kolter, “MurA (MurZ), the enzyme that catalyzes the first committed step in peptidoglycan biosynthesis, is essential in Escherichia coli,” Journal of Bacteriology, vol. 177, no. 14, pp. 4194–4197, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. F. M. Kahan, J. S. Kahan, P. J. Cassidy, and H. Kropp, “The mechanism of action of fosfomycin (phosphonomycin),” Annals of the New York Academy of Sciences, vol. 235, no. 1, pp. 364–386, 1974. View at Publisher · View at Google Scholar · View at Scopus
  14. M. J. Lemieux, Y. Huang, and D.-N. Wang, “Glycerol-3-phosphate transporter of Escherichia coli: structure, function and regulation,” Research in Microbiology, vol. 155, no. 8, pp. 623–629, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. H. H. Winkler, “Kinetics of exogenous induction of the hexose-6-phosphate transport system of Escherichia coli,” Journal of Bacteriology, vol. 107, no. 1, pp. 74–78, 1971. View at Google Scholar · View at Scopus
  16. T. J. Merkel, J. L. Dahl, R. H. Ebright, and R. J. Kadner, “Transcription activation at the Escherichia coli uhpT promoter by the catabolite gene activator protein,” Journal of Bacteriology, vol. 177, no. 7, pp. 1712–1718, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. D. T. Verhamme, P. W. Postma, W. Crielaard, and K. J. Hellingwerf, “Cooperativity in signal transfer through the Uhp system of Escherichia coli,” Journal of Bacteriology, vol. 184, no. 15, pp. 4205–4210, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Takahata, T. Ida, T. Hiraishi et al., “Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli,” International Journal of Antimicrobial Agents, vol. 35, no. 4, pp. 333–337, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Wachino, K. Yamane, S. Suzuki, K. Kimura, and Y. Arakawa, “Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 7, pp. 3061–3064, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Kurabayashi, Y. Hirakawa, K. Tanimoto, H. Tomita, and H. Hirakawa, “Role of the CpxAR two-component signal transduction system in control of fosfomycin resistance and carbon substrate uptake,” Journal of Bacteriology, vol. 196, no. 2, pp. 248–256, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Arca, G. Reguera, and C. Hardisson, “Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey,” Journal of Antimicrobial Chemotherapy, vol. 40, no. 3, pp. 393–399, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Hou, X. Huang, Y. Deng et al., “Dissemination of the fosfomycin resistance gene fosA3 with CTX-M β-lactamase genes and rmtB carried on incfII plasmids among Escherichia coli isolates from pets in China,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 4, pp. 2135–2138, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. S.-Y. Lee, Y.-J. Park, J. K. Yu et al., “Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3,” Journal of Antimicrobial Chemotherapy, vol. 67, no. 12, Article ID dks319, pp. 2843–2847, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. P. L. Ho, J. Chan, W. U. Lo et al., “Prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes among blood and urinary Escherichia coli isolates,” Journal of Medical Microbiology, vol. 62, no. 11, pp. 1707–1713, 2013. View at Publisher · View at Google Scholar
  25. G. Nakamura, J. Wachino, N. Sato et al., “Practical agar-based disk potentiation test for detection of fosfomycin-nonsusceptible Escherichia coli clinical isolates producing glutathione S-transferases,” Journal of Clinical Microbiology, vol. 52, no. 9, pp. 3175–3179, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Ma, X. Xu, Q. Guo, P. Wang, W. Wang, and M. Wang, “Characterization of fosA5, a new plasmid-mediated fosfomycin resistance gene in Escherichia coli,” Letters in Applied Microbiology, vol. 60, no. 3, pp. 259–264, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Li, B. Zheng, Y. Li, S. Zhu, F. Xue, and J. Liu, “Antimicrobial susceptibility and molecular mechanisms of fosfomycin resistance in clinical Escherichia coli isolates in mainland China,” PLoS ONE, vol. 10, no. 8, Article ID e0135269, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. S.-P. Tseng, S.-F. Wang, C.-Y. Kuo et al., “Characterization of fosfomycin resistant extended-spectrum ß-lactamase-producing Escherichia coli isolates from human and pig in Taiwan,” PLoS ONE, vol. 10, no. 8, Article ID e0135864, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. A. I. Nilsson, O. G. Berg, O. Aspevall, G. Kahlmeter, and D. I. Andersson, “Biological costs and mechanisms of fosfomycin resistance in Escherichia coli,” Antimicrobial Agents and Chemotherapy, vol. 47, no. 9, pp. 2850–2858, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. J. C. Cordaro, T. Melton, J. P. Stratis et al., “Fosfomycin resistance: selection method for internal and extended deletions of the phosphoenolpyruvate:sugar phosphotransferase genes of Salmonella typhimurium,” Journal of Bacteriology, vol. 128, no. 3, pp. 785–793, 1976. View at Google Scholar · View at Scopus
  31. Y. Sakamoto, S. Furukawa, H. Ogihara, and M. Yamasaki, “Fosmidomycin resistance in adenylate cyclase deficient (cya) mutants of Escherichia coli,” Bioscience, Biotechnology and Biochemistry, vol. 67, no. 9, pp. 2030–2033, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Kahlmeter and H. O. Poulsen, “Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited,” International Journal of Antimicrobial Agents, vol. 39, no. 1, pp. 45–51, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. D. E. Karageorgopoulos, R. Wang, X.-H. Yu, and M. E. Falagas, “Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in gram-negative pathogens,” Journal of Antimicrobial Chemotherapy, vol. 67, no. 2, pp. 255–268, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing, 22nd Information Supplement, M100-S22, CLSI, Wayne, Pa, USA, 2012.
  35. O. Clermont, J. R. Johnson, M. Menard, and E. Denamur, “Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia,” Diagnostic Microbiology and Infectious Disease, vol. 57, no. 2, pp. 129–136, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Li, B. Liu, M. Chen et al., “A multiplex PCR method to detect 14 Escherichia coli serogroups associated with urinary tract infections,” Journal of Microbiological Methods, vol. 82, no. 1, pp. 71–77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. O. Clermont, S. Bonacorsi, and E. Bingen, “Rapid and simple determination of the Escherichia coli phylogenetic group,” Applied and Environmental Microbiology, vol. 66, no. 10, pp. 4555–4558, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Y. Tartof, O. D. Solberg, A. R. Manges, and L. W. Riley, “Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing,” Journal of Clinical Microbiology, vol. 43, no. 12, pp. 5860–5864, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. R. J. Kadner and H. H. Winkler, “Isolation and characterization of mutations affecting the transport of hexose phosphates in Escherichia coli,” Journal of Bacteriology, vol. 113, no. 2, pp. 895–900, 1973. View at Google Scholar · View at Scopus